DK158972C - Farmaceutiske formuleringer indeholdende benzothiophenderivater - Google Patents

Farmaceutiske formuleringer indeholdende benzothiophenderivater

Info

Publication number
DK158972C
DK158972C DK434884A DK434884A DK158972C DK 158972 C DK158972 C DK 158972C DK 434884 A DK434884 A DK 434884A DK 434884 A DK434884 A DK 434884A DK 158972 C DK158972 C DK 158972C
Authority
DK
Denmark
Prior art keywords
derivatives
benzothiophender
formulas containing
pharmaceutical formulas
pharmaceutical
Prior art date
Application number
DK434884A
Other languages
English (en)
Other versions
DK434884A (da
DK434884D0 (da
DK158972B (da
Inventor
Peter Peck Koh Ho
Quentin Francis Soper
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK434884D0 publication Critical patent/DK434884D0/da
Publication of DK434884A publication Critical patent/DK434884A/da
Publication of DK158972B publication Critical patent/DK158972B/da
Application granted granted Critical
Publication of DK158972C publication Critical patent/DK158972C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Seal Device For Vehicle (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
DK434884A 1983-09-13 1984-09-12 Farmaceutiske formuleringer indeholdende benzothiophenderivater DK158972C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/531,802 US4552891A (en) 1983-09-13 1983-09-13 Benzothiophene derivatives
US53180283 1983-09-13

Publications (4)

Publication Number Publication Date
DK434884D0 DK434884D0 (da) 1984-09-12
DK434884A DK434884A (da) 1985-03-14
DK158972B DK158972B (da) 1990-08-13
DK158972C true DK158972C (da) 1991-01-07

Family

ID=24119104

Family Applications (1)

Application Number Title Priority Date Filing Date
DK434884A DK158972C (da) 1983-09-13 1984-09-12 Farmaceutiske formuleringer indeholdende benzothiophenderivater

Country Status (18)

Country Link
US (1) US4552891A (da)
EP (1) EP0139464B1 (da)
JP (1) JPS6084221A (da)
AT (1) ATE38036T1 (da)
AU (1) AU563650B2 (da)
CA (1) CA1229047A (da)
CY (1) CY1513A (da)
DE (2) DE3433475A1 (da)
DK (1) DK158972C (da)
GB (1) GB2146527B (da)
HK (1) HK38990A (da)
IL (1) IL72928A (da)
IT (1) IT1176702B (da)
MY (1) MY101614A (da)
NZ (1) NZ209516A (da)
PH (1) PH21102A (da)
SG (1) SG74789G (da)
ZA (1) ZA847193B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0253650A3 (en) * 1986-07-18 1989-09-13 Eli Lilly And Company Improvements relating to benzothiophene derivatives
GB8816519D0 (en) * 1987-07-23 1988-08-17 Ici Plc Antibiotic compounds
US4863923A (en) * 1988-07-01 1989-09-05 Eli Lilly And Company Method of inhibiting superoxide release
EP0915090A1 (en) * 1992-09-10 1999-05-12 Eli Lilly And Company Compounds useful as hypoglycemic agents and for treating Alzheimer's disease
US6251928B1 (en) * 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
US6187790B1 (en) 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
US6426084B1 (en) * 2000-06-19 2002-07-30 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6132757A (en) * 1998-05-01 2000-10-17 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
MXPA02001830A (es) 1999-08-21 2002-08-12 Byk Gulden Lomberg Chem Fab Combinacion sinergica de inhibidores de pde y agonista de beta 2 adrenoceptor.
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US6458804B1 (en) 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US6562838B2 (en) * 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
US20030096748A1 (en) * 2001-06-04 2003-05-22 The Regents Of The University Of Michigan Methods and compositions for the treatment of diseases associated with signal transduction aberrations
US7041677B2 (en) * 2002-03-01 2006-05-09 R.T. Alamo Ventures I, Llc Use of monochloroflosequinan in the treatment of sexual dysfunction
US7208628B2 (en) * 2002-05-13 2007-04-24 Kansas State University Research Foundation Compositions and methods for the treatment of hepatitis C virus infection
US7074893B2 (en) * 2002-06-03 2006-07-11 Regents Of The University Of Michigan Methods and compositions for the treatment of diseases associated with signal transduction aberrations
EA200501548A1 (ru) 2003-04-01 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. Ингибиторы фосфодиэстераз при бесплодии
US20050089558A1 (en) * 2003-10-28 2005-04-28 Alamo Pharmaceuticals, Llc Compositions and methods for the co-formulation and administration of tramadol and propoxyphene
WO2007098010A2 (en) * 2006-02-17 2007-08-30 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Improved low molecular weight myc-max inhibitors
US10494405B2 (en) 2015-05-15 2019-12-03 The Regents Of The University Of Michigan Methods and compositions for the treatment of arthritis
MX2020004566A (es) 2017-11-07 2020-08-13 Univ Michigan Regents Inhibidores de molécula pequeña de interacciones de epítopo compartido-calreticulina y métodos de uso.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH508615A (de) * 1968-05-30 1971-06-15 Ciba Geigy Ag Verfahren zur Herstellung von neuen heterocyclischen Carbonsäuren
US4101668A (en) * 1977-05-10 1978-07-18 Bristol-Myers Company Antiosteoporotic agents

Also Published As

Publication number Publication date
GB2146527B (en) 1987-05-20
DK434884A (da) 1985-03-14
IT1176702B (it) 1987-08-18
SG74789G (en) 1990-04-20
ATE38036T1 (de) 1988-11-15
AU3192084A (en) 1985-03-21
PH21102A (en) 1987-07-16
ZA847193B (en) 1986-04-30
MY101614A (en) 1991-12-17
EP0139464B1 (en) 1988-10-19
EP0139464A1 (en) 1985-05-02
IT8422626A0 (it) 1984-09-12
GB2146527A (en) 1985-04-24
US4552891A (en) 1985-11-12
CA1229047A (en) 1987-11-10
DE3433475A1 (de) 1985-03-28
DE3474662D1 (en) 1988-11-24
HK38990A (en) 1990-05-25
AU563650B2 (en) 1987-07-16
DK434884D0 (da) 1984-09-12
JPS6084221A (ja) 1985-05-13
DE3433475C2 (da) 1992-12-24
GB8423081D0 (en) 1984-10-17
NZ209516A (en) 1987-01-23
IL72928A (en) 1987-10-20
CY1513A (en) 1990-08-03
IL72928A0 (en) 1984-12-31
DK158972B (da) 1990-08-13

Similar Documents

Publication Publication Date Title
DK158972C (da) Farmaceutiske formuleringer indeholdende benzothiophenderivater
IT1164626B (it) Procedimento per il ricupero di ifn-b umano da microorganismi produttori trasformati
NO165375C (no) Instrument for behandling av luftveishindringer.
IT8447911A1 (it) Apparecchiatura per il trattamento di bottiglia e simili.
FI891986A (fi) Farmaceutiska sammansaettningar foer behandling av psoriasis.
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
NO881436D0 (no) Fremgangsmaate for matriksbehandling av en oljebroenn.
DK585984A (da) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan og salte deraf til anvendelse ved bekaempelse af sygdomme samt fremgangsmaade til fremstilling af saadanne nonanderivater
DE3462129D1 (de) Terphenyl derivatives
IT1151104B (it) Impiego terapeutico di derivati (1-cinnamoil oppure 1-fenetil-carbonil)piperazinici
EP0253650A3 (en) Improvements relating to benzothiophene derivatives
GR3005231T3 (da)
IT8020156A0 (it) Metodo per la sterilizzazione dimateriali.
IT1189033B (it) Apparecchio ortopedico e procedimento di applicazione
IT1217262B (it) Procedimento di preparazione dei filari per viti e dispositivi preposti all'attuazione di tale procedimento
NO892660D0 (no) Fremgangsmaate for reendotelialisering av kar-innsider.
IT8422685A0 (it) Composizione farmaceutica eprocedimento per il trattamento di eccetazione psicomotoria.
NO871797D0 (no) Fremgangsmaate og anordning for anbringelse av blindnagler.
NO830614L (no) Fremgangsmaate for behandling av glaukom.
DK15286D0 (da) Epoxider og anvendelsen heraf som mellemprodukt

Legal Events

Date Code Title Description
PBP Patent lapsed